British Journal of Pharmacology · 2001 · 63 citations · 28 references
MedicinePharmacologyMolecular PharmacologyPharmacodynamicsTissue EngineeringAngiogenesisFlap SalvageFlap SurgeryAngiogenesis ImpairmentAngiogenic ResponseFlap SurvivalNitric OxideNitric Oxide ProductionNitric Oxide Synthase RegulationSkin Flap NecrosisVascular Endothelial Growth Factor
We have examined the role of nitric oxide (NO) in a model of functional angiogenesis in which survival of a skin flap depends entirely on angiogenesis to provide an arterial blood supply to maintain tissue viability. The different effects of nitric oxide synthase (NOS) inhibitors on rat skin flap survival appeared to be explained on the basis of their NOS isoform selectivity. Skin flap survival was decreased by iNOS-selective (inducible NOS) inhibitors, S-methyl-isothiourea, aminoguanidine and aminoethylthiorea; unaffected by the non-selective inhibitor nitro-imino-L-ornithine; and enhanced by the cNOS (constitutive NOS, that is endothelial NOS (eNOS) and neuronal NOS (nNOS)) inhibitor, nitro-L-arginine methyl ester. Skin flap survival was reduced in mice with targeted disruption of the iNOS gene (iNOS knockout mice), and the administration of nitro-L-arginine methyl ester significantly increased flap survival in iNOS knockout mice (P<0.05). iNOS immunoreactivity was identified in mast cells in the angiogenic region. Immunoreactive vascular endothelial growth factor (VEGF) and basic fibroblast growth factor were also localized to mast cells. The combination of interferon-gamma and tumour necrosis factor-alpha induced NO production and increased VEGF levels in mast cells cultured from bone marrow of wild-type, but not iNOS KO mice. The increased tissue survival associated with the capacity for iNOS expression may be related to iNOS-dependent enhancement of VEGF levels and an ensuing angiogenic response. Our results provide both pharmacological and genetic evidence that iNOS activity promotes survival of ischaemic tissue.
28
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Laura C. Green, David A. Wagner, Joseph A. Glogowski et al. · Analytical Biochemistry · 1982 · 12.1K citations
Vascular endothelial growth factor (VEGF) and its receptors
Gera Neufeld, Tzafra Cohen, Stela Gengrinovitch et al. · The FASEB Journal · 1999 · 3.5K citations
Medicine, Cell Biology, Oncology +17
John D. MacMicking, Carl Nathan, Gary Hom et al. · Cell · 1995 · 1.4K citations · Full text
Andreas Papapetropoulos, Guillermo García‐Cardeña, Joseph A. Madri et al. · Journal of Clinical Investigation · 1997 · 1.2K citations · Full text
Marina Ziche, Lucia Morbidelli, Rangana Choudhuri et al. · Journal of Clinical Investigation · 1997 · 917 citations · Full text
Medicine, Cancer Biology, Oncology +16